Key information
Delivery type
Hybrid – Face to face or online
Delivery style
- Face-to-face (in-person teaching sessions at a specific venue)
- Online (live)
Duration
One day
Experience level
All
Cost
- Onsite: £110
- Virtual: £110
- Low- and Middle-Income Countries (LMIC): £50
- Student: £70
- Offer 5 for 4 (onsite and virtual): £84
- Pharma and industry: £200
Book on the Immunotherapy Checkpoint Inhibitors in Oncology Study Day on 24 November and the Bispecific Antibodies in Oncology Study Day on 8 December and receive a 10% discount from the booking price.
08:30 - Registration
09:00 - Welcome and Introduction
09:20 - Bispecific Antibodies: Mechanism, Indications and NHS Context
10:10 - Neurosurgery Including Oncological Emergencies
11:00 - Break
11:15 - Operational Delivery Models
12:00 - Lunch
13:00 - Interactive MDT Simulation: Managing a Deteriorating Patient
14:00 - Documentation, Escalation and Safety Netting
14:45 - Break
15:00 - Service Development and Future Directions
15:45 - Closing and Evaluation
What to expect
Bispecific antibodies are reshaping the immunotherapy landscape, delivering remarkable responses across haematological malignancies and an expanding range of solid tumours. As these novel agents move from clinical trials into routine practice, healthcare professionals need to understand how they work, who they're for, and how to manage their unique toxicity profile safely and effectively.
This study day provides a practical update on bispecific antibodies in oncology, equipping clinicians across all disciplines to support timely, effective and personalised care for patients.
Learning outcomes
By the end of this study day, delegates will be able to:
- Describe the mechanism of action of bispecific antibodies and their role across haematological malignancies and solid tumours
- Identify appropriate patient selection criteria and relevant biomarkers to guide bispecific antibody therapy
- Recognise the clinical features and grading of Cytokine Release Syndrome (CRS) and implement evidence-based management strategies
- Identify and manage neurological toxicities associated with bispecific antibodies, including Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS)
- Apply evidence-based approaches to the management of bispecific-related adverse events, including complex and rare toxicities
- Explain step-up dosing protocols, hospitalisation requirements, and practical considerations for the safe delivery of bispecific antibody treatment
- Demonstrate confidence in nursing care and patient safety practices specific to patients receiving bispecific antibody therapy
Why choose this programme
This study day offers an up-to-date and clinically relevant overview of immune checkpoint inhibitors, combining current evidence, practical toxicity management and multidisciplinary perspectives to support safer and more effective patient care.
Who is it for?
Healthcare professionals involved in treating patients on immunotherapy, academics involved in cancer research, and anyone with an interest in this field.
How to book/learn more
You can book this course on Eventbrite.
Not ready to book? Find out more
What's new?
The Christie Institute news-
Read more about Paterson Programme Impact Report now livePaterson Programme Impact Report now live
The Paterson Programme was established within The Christie Institute of Cancer Education to provide psychologically informed coaching, mentoring and professional development support for residents, fellows, specialty doctors and educators working within oncology and related specialties.
-
Read more about Championing opportunity through our partnership with WorkFit and the Down’s Syndrome AssociationChampioning opportunity through our partnership with WorkFit and the Down’s Syndrome Association
We’ve had the pleasure of working alongside WorkFit, the Down’s Syndrome Association’s employment programme, to support young people with Down syndrome through work experience opportunities at The Christie.
-
Read more about SACT in Motion event recap: bringing cancer treatment closer to homeSACT in Motion event recap: bringing cancer treatment closer to home
The Christie Institute for Cancer Education hosted SACT in Motion: Your Care, Your Community, Your Home on 13 July 2026 exploring how systemic anti-cancer therapy (SACT) services are evolving across Greater Manchester.